DeutschNewstral
Article
Reuters on 2017-04-07 23:48
Germany's Fresenius in talks to buy generic drugmaker Akorn
Related news
- MGermany's Fresenius Kabi to buy Akorn for $4.3 billionmarketwatch.com
- MAkorn shares surge 20% on report Germany's Fresenius is mulling a bidmarketwatch.com
Akorn suitor Fresenius abandons $4.3 billion takeover bidChicago Tribune- Lake Forest drugmaker Akorn confirms it's in takeover talks with German pharma giantChicago Tribune
Fresenius abandons $4.3 billion Akorn dealdailyherald.com
Akorn Shares Plunge as Fresenius Investigates Companywsj.com- FGerman generic drugmaker warns against EU protectionismft.com
- MAkorn files complaint against Fresenius for ending merger dealmarketwatch.com
- Akorn Vows to Fight Fresenius Decision to End Dealwsj.com
- FCourt rules Fresenius can ditch $4.75bn Akorn dealft.com
Germany’s Fresenius, US-based Akorn at odds over merger dealSeattle Times- MGeneric drugmaker ETF could outperform biotech peers under Clintonmarketwatch.com
- Akorn CEO steps down after loss of $4.3 billion Fresenius dealdailyherald.com
- MAkorn stock set to drop nearly 50% after court supports Fresenius ending $4.3 bln mergermarketwatch.com
- Drugmaker Ipsen to buy some products from Sanofi for 83 million eurosReuters
Generic drugmaker Mylan offers to buy Perrigo for $29 billionHaaretz- Generic drugmaker Mylan's profit benefits from Meda buyReuters
Germany's HeidelbergCement to buy Italcementidothaneagle.com
Canadian drugmaker Apotex issues recall of generic Zantac in U.S. over carcinogen fearsbusiness.financialpost.com